These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
466 related items for PubMed ID: 15591662
1. Linezolid. Narang M, Gomber S. Indian Pediatr; 2004 Nov; 41(11):1129-32. PubMed ID: 15591662 [Abstract] [Full Text] [Related]
2. Use of linezolid in children: an overview of recent advances. Velissariou IM. Expert Rev Anti Infect Ther; 2006 Dec; 4(6):947-52. PubMed ID: 17181410 [Abstract] [Full Text] [Related]
3. Oxazolidinone antibiotics. Diekema DJ, Jones RN. Lancet; 2001 Dec 08; 358(9297):1975-82. PubMed ID: 11747939 [Abstract] [Full Text] [Related]
5. Linezolid, the first oxazolidinone antibacterial agent. Leach KL, Brickner SJ, Noe MC, Miller PF. Ann N Y Acad Sci; 2011 Mar 08; 1222():49-54. PubMed ID: 21434942 [Abstract] [Full Text] [Related]
8. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Pediatr Infect Dis J; 2003 Sep 08; 22(9 Suppl):S158-63. PubMed ID: 14520141 [Abstract] [Full Text] [Related]
9. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection. Seedat J, Zick G, Klare I, Konstabel C, Weiler N, Sahly H. Antimicrob Agents Chemother; 2006 Dec 08; 50(12):4217-9. PubMed ID: 16982791 [Abstract] [Full Text] [Related]
10. Experience with linezolid therapy in children with osteoarticular infections. Chen CJ, Chiu CH, Lin TY, Lee ZL, Yang WE, Huang YC. Pediatr Infect Dis J; 2007 Nov 08; 26(11):985-8. PubMed ID: 17984803 [Abstract] [Full Text] [Related]
11. Linezolid--a review of the first oxazolidinone. Norrby R. Expert Opin Pharmacother; 2001 Feb 08; 2(2):293-302. PubMed ID: 11336587 [Abstract] [Full Text] [Related]
12. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Jantausch BA, Deville J, Adler S, Morfin MR, Lopez P, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Pediatr Infect Dis J; 2003 Sep 08; 22(9 Suppl):S164-71. PubMed ID: 14520142 [Abstract] [Full Text] [Related]
15. Quinupristin-dalfopristin and linezolid: evidence and opinion. Eliopoulos GM. Clin Infect Dis; 2003 Feb 15; 36(4):473-81. PubMed ID: 12567306 [Abstract] [Full Text] [Related]
16. [Linezolid, an agent from a new class of antibiotics]. Kuijper EJ, Schippers EF, Bernards AT. Ned Tijdschr Geneeskd; 2004 Aug 07; 148(32):1577-81. PubMed ID: 15382556 [Abstract] [Full Text] [Related]
17. Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections. Ament PW, Jamshed N, Horne JP. Am Fam Physician; 2002 Feb 15; 65(4):663-70. PubMed ID: 11871684 [Abstract] [Full Text] [Related]
18. Linezolid for the treatment of complicated skin and skin structure infections in children. Yogev R, Patterson LE, Kaplan SL, Adler S, Morfin MR, Martin A, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Pediatr Infect Dis J; 2003 Sep 15; 22(9 Suppl):S172-7. PubMed ID: 14520143 [Abstract] [Full Text] [Related]
19. Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class. Nilius AM. Curr Opin Investig Drugs; 2003 Feb 15; 4(2):149-55. PubMed ID: 12669374 [Abstract] [Full Text] [Related]